Robuta

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0237693 Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study | PLOS One Hydroxychloroquine has been touted as a potential COVID-19 treatment. Tocilizumab, an inhibitor of IL-6, has also been proposed as a treatment of critically... covid 19 plos one hydroxychloroquine tocilizumab therapy https://pmc.ncbi.nlm.nih.gov/articles/PMC8473718/ Implications for Systemic Approaches to COVID-19: Effect Sizes of Remdesivir, Tocilizumab,... COVID-19 poses a chronic threat to inflammatory systems, reinforcing the need for efficient anti-inflammatory strategies. The purpose of this review and... covid 19 implications approaches effect sizes https://www.jmir.org/2020/9/e21758 Journal of Medical Internet Research - Efficacy of Hydroxychloroquine and Tocilizumab in Patients... Background: During the initial phases of the COVID-19 pandemic, there was an unfounded fervor surrounding the use of hydroxychloroquine (HCQ) and tocilizumab... internet research journal medical efficacy hydroxychloroquine